Nordea Investment Management AB Grows Position in HealthEquity, Inc. (NASDAQ:HQY)

Nordea Investment Management AB boosted its stake in shares of HealthEquity, Inc. (NASDAQ:HQY) by 4.8% during the fourth quarter, HoldingsChannel.com reports. The firm owned 59,812 shares of the company’s stock after acquiring an additional 2,757 shares during the period. Nordea Investment Management AB’s holdings in HealthEquity were worth $5,747,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in the stock. Paladin Wealth LLC acquired a new position in HealthEquity during the third quarter valued at approximately $39,000. Point72 Asia Singapore Pte. Ltd. acquired a new position in shares of HealthEquity during the 2nd quarter valued at $73,000. GAMMA Investing LLC boosted its position in HealthEquity by 57.8% during the 3rd quarter. GAMMA Investing LLC now owns 939 shares of the company’s stock worth $77,000 after purchasing an additional 344 shares during the period. Quarry LP boosted its position in HealthEquity by 418.8% during the 3rd quarter. Quarry LP now owns 1,349 shares of the company’s stock worth $110,000 after purchasing an additional 1,089 shares during the period. Finally, 1620 Investment Advisors Inc. acquired a new stake in HealthEquity in the 3rd quarter valued at $112,000. Institutional investors and hedge funds own 99.55% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the company. The Goldman Sachs Group began coverage on HealthEquity in a research report on Friday, November 15th. They issued a “neutral” rating and a $108.00 target price for the company. Bank of America increased their price objective on shares of HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a research report on Wednesday, November 13th. BTIG Research boosted their target price on shares of HealthEquity from $110.00 to $130.00 and gave the stock a “buy” rating in a research report on Thursday, November 14th. Barrington Research raised their price target on shares of HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Monday, December 2nd. Finally, Mizuho started coverage on shares of HealthEquity in a report on Wednesday, December 4th. They issued an “outperform” rating and a $126.00 price objective on the stock. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $110.71.

HealthEquity Trading Up 1.1 %

Shares of NASDAQ HQY opened at $99.74 on Friday. The stock has a market capitalization of $8.64 billion, a P/E ratio of 91.50, a PEG ratio of 1.08 and a beta of 0.54. The stock’s 50 day moving average price is $97.86 and its two-hundred day moving average price is $85.89. The company has a quick ratio of 4.10, a current ratio of 3.20 and a debt-to-equity ratio of 0.51. HealthEquity, Inc. has a 52-week low of $65.01 and a 52-week high of $105.82.

Insider Activity at HealthEquity

In other news, Director Frank Corvino sold 1,039 shares of the stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the sale, the director now directly owns 3,784 shares in the company, valued at approximately $363,642.40. This represents a 21.54 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Stuart B. Parker sold 25,000 shares of the business’s stock in a transaction that occurred on Thursday, December 12th. The shares were sold at an average price of $96.72, for a total value of $2,418,000.00. Following the transaction, the director now owns 19,061 shares of the company’s stock, valued at $1,843,579.92. This represents a 56.74 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 34,289 shares of company stock valued at $3,355,718. Corporate insiders own 2.20% of the company’s stock.

HealthEquity Company Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.